Literature DB >> 11056294

Paternal exposure to cyclophosphamide induces DNA damage and alters the expression of DNA repair genes in the rat preimplantation embryo.

W Harrouk1, A Codrington, R Vinson, B Robaire, B F Hales.   

Abstract

Chronic low dose treatment of male rats with cyclophosphamide, an anticancer alkylating agent, damages male germ cells, resulting in greater than 80% peri-implantation progeny loss. Little transcription or repair takes place in the DNA of post-meiotic male germ cells. The spermatozoal genome regains its transcriptional capacity in the fertilized oocyte. We hypothesized that as a consequence of exposure of male rats to cyclophosphamide DNA damage to the male genome is transmitted to the conceptus; furthermore, this damage leads to alterations in the expression profiles of DNA repair genes during preimplantation development. Male rats were treated with either saline or cyclophosphamide (6mg/kg/day, 4-6 weeks) and mated to control females; 1-8 cell stage embryos were collected. The alkaline comet assay was used to assess DNA damage in 1-cell embryos. A significantly higher percentage (68%) of the embryos fertilized by cyclophosphamide-exposed spermatozoa displayed a comet indicative of DNA damage, compared to those sired by control males (18%). The in situ transcription/antisense RNA approach was used to determine if DNA damage alters the expression of DNA repair genes in early embryos. Dramatic increases in the transcripts for selected members of the nucleotide excision repair family (XPC, XPE and PCNA), mismatch repair family (PMS1), and recombination repair family (RAD50) were found in 1-cell stage embryos sired by cyclophosphamide-treated males compared to controls, while decreases in the expression of base excision repair family members (UNG1, UNG2, and XRCC1) and in recombination repair transcripts (RAD54) were observed. By the 8-cell stage, transcripts for specific members of the nucleotide excision repair family (XPC) and mismatch repair family (MSH2, PMS2) were elevated greatly in control embryos compared to embryos sired by drug-treated males; in contrast, transcripts for other members of the nucleotide excision repair family (XPE, PCNA), as well as some of the base excision repair family (UNG1), were elevated in embryos sired by drug-treated males. Therefore, DNA damage incurred in spermatozoa, following cyclophosphamide exposure is associated with alterations in the expression profiles of DNA repair genes in preimplantation embryos as early as the 1-cell stage. Genotoxic stress may disturb the nuclear remodeling and reprogramming events that follow fertilization and precede zygotic genome activation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11056294     DOI: 10.1016/s0921-8777(00)00053-7

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  10 in total

1.  Epigenetic programming in the preimplantation rat embryo is disrupted by chronic paternal cyclophosphamide exposure.

Authors:  Tara S Barton; Bernard Robaire; Barbara F Hales
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-23       Impact factor: 11.205

Review 2.  The sperm nucleus: chromatin, RNA, and the nuclear matrix.

Authors:  Graham D Johnson; Claudia Lalancette; Amelia K Linnemann; Frédéric Leduc; Guylain Boissonneault; Stephen A Krawetz
Journal:  Reproduction       Date:  2010-09-27       Impact factor: 3.906

3.  Germ-line mutations, DNA damage, and global hypermethylation in mice exposed to particulate air pollution in an urban/industrial location.

Authors:  Carole Yauk; Aris Polyzos; Andrea Rowan-Carroll; Christopher M Somers; Roger W Godschalk; Frederik J Van Schooten; M Lynn Berndt; Igor P Pogribny; Igor Koturbash; Andrew Williams; George R Douglas; Olga Kovalchuk
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-14       Impact factor: 11.205

Review 4.  Biochemical alterations in the oocyte in support of early embryonic development.

Authors:  Jacinta H Martin; Elizabeth G Bromfield; R John Aitken; Brett Nixon
Journal:  Cell Mol Life Sci       Date:  2016-09-07       Impact factor: 9.261

5.  Genetic mechanisms of formation of radiation-induced instability of the genome and its transgenerational effects in the descendants of chronically irradiated individuals of Drosophila melanogaster.

Authors:  Elena Yushkova
Journal:  Radiat Environ Biophys       Date:  2020-02-19       Impact factor: 1.925

6.  Effects of the insemination of hydrogen peroxide-treated epididymal mouse spermatozoa on γH2AX repair and embryo development.

Authors:  Jianfeng Xiao; Yanmei Liu; Zhiling Li; Yongcui Zhou; Hong Lin; Xiaoyan Wu; Man Chen; Wanfen Xiao
Journal:  PLoS One       Date:  2012-06-26       Impact factor: 3.240

7.  Paternal cyclophosphamide exposure induces the formation of functional micronuclei during the first zygotic division.

Authors:  Lisanne Grenier; Bernard Robaire; Barbara F Hales
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

8.  Evaluation of the Biological Efficiency of Silver Nanoparticles Biosynthesized Using Croton tiglium L. Seeds Extract against Azoxymethane Induced Colon Cancer in Rats.

Authors:  Wael Mahmoud Aboulthana; Noha El-Sayed Ibrahim; Noha Mohamed Osman; Mohamed Mahmoud Seif; Amgad Kamal Hassan; Ahmed Mahmoud Youssef; Amal Mostafa El-Feky; A A Madboli
Journal:  Asian Pac J Cancer Prev       Date:  2020-05-01

9.  Breast tumors with elevated expression of 1q candidate genes confer poor clinical outcome and sensitivity to Ras/PI3K inhibition.

Authors:  Muthulakshmi Muthuswami; Vignesh Ramesh; Saikat Banerjee; Soundara Viveka Thangaraj; Jayaprakash Periasamy; Divya Bhaskar Rao; Georgina D Barnabas; Swetha Raghavan; Kumaresan Ganesan
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

10.  In vitro developmental ability of ovine oocytes following intracytoplasmic injection with freeze-dried spermatozoa.

Authors:  Maite Olaciregui; Victoria Luño; Paula Domingo; Noelia González; Lydia Gil
Journal:  Sci Rep       Date:  2017-04-24       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.